Short answer
Tempus AI Inc (TEM) filed an 8-K current report with the SEC on July 20, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Tempus announced a merger agreement to acquire Personalis through a two-step merger structure.
Tempus AI Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Tempus announced a merger agreement to acquire Personalis through a two-step merger structure
- Personalis would become a wholly owned Tempus subsidiary, expanding Tempus’ genomics and data capabilities
- Transaction requires Personalis stockholder approval and regulatory clearances before closing
- Personalis may terminate if Tempus Class A shares fall below $46.00 before closing
- Tempus plans an S-4 registration statement and joint Schedule 13E-3, creating upcoming disclosure and approval milestones
Item EX-99.1 · Exhibit EX-99.1
- Tempus agreed to acquire Personalis for $16.25 per share, valuing the transaction at $1.5 billion net of existing ownership
- 100% stock consideration, with Tempus able to fund up to 50% in cash using cash and credit facilities
- Strategic expansion into the $20 billion MRD market, combining Personalis’ testing technology with Tempus’ AI, data and commercial platform
- Personalis Q2 preliminary revenue $22.4 million and 10,384 clinical tests, up 33% quarter over quarter
- Closing expected late 2026 or early 2027, subject to shareholder and regulatory approvals, with potential dilution and integration execution risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tempus AI Inc 8-K filings
Get the next TEM 8-K as it lands
Follow TEM for push alerts, or ask the research agent what this filing means.